Raoul Announces $29.6 Million Glenmark Settlement in Generic Drug Price-Fixing Case
Glenmark will pay monetary relief and cooperate in ongoing antitrust litigation after states alleged it helped inflate prices on generic drugs.
- On Wednesday, July 15, a coalition of 48 attorneys general announced a $29.6 million settlement with Glenmark Pharmaceuticals, resolving allegations the manufacturer engaged in a long-running conspiracy to artificially inflate generic drug prices.
- Lawsuits allege Glenmark executives negotiated illegal agreements during industry events, using terms like "fair share" and "playing fair" to coordinate price increases and discourage competition.
- Investigators built the case using evidence from over 20 million documents, revealing that coordinated price increases for medications ranging from antibiotics to cancer treatments exceeded 1,000%.
- Consumers who purchased specific generic drugs between May 2009 and December 2019 may be eligible for compensation, while Glenmark agreed to cooperate in ongoing litigation against 33 corporate defendants and 25 individual executives.
- Glenmark agreed to an injunctive relief period of at least seven years to support fair competition, as the first landmark trial in the broader litigation is scheduled for late 2026.
24 Articles
24 Articles
Wisconsin joins $29.6 million settlement with generic drug maker over alleged price-fixing
MADISON, Wis. — Wisconsin has joined a $29.6 million multistate settlement with generic drug manufacturer Glenmark to resolve allegations the company participated in a long-running conspiracy to inflate prescription drug prices and limit competition. The settlement, announced Wednesday by the Wisconsin Department of Justice, includes 48 states and territories. It resolves allegations that Glenmark worked […] The post Wisconsin joins $29.6 millio…
Raoul Announces $29.6 Million Glenmark Settlement in Generic Drug Price-Fixing Case
CHICAGO – Attorney General Kwame Raoul, along with a coalition of 48 attorneys general, today announced a $29.6 million settlement with Glenmark, resolving allegations the generic drug manufacturer engaged in a widespread and long-running conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade with regard to numerous generic prescription drugs.Today’s settlement comes after Raoul and the coali…
Coverage Details
Bias Distribution
- 84% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
